Medtronic expands coronary portfolio

Medical Devices Directory Forums Product & Service Medtronic expands coronary portfolio

This topic contains 0 replies, has 1 voice, and was last updated by Profile photo of Brückenkopf GmbH Brückenkopf GmbH 4 months, 1 week ago.

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #3259

    Medtronic plc announced that its market-leading coronary portfolio will now include the DxTerity Diagnostic Angiography Catheter line and several transradial-specific products including the DxTerity TRA(TM), InTRAkit(TM) access kit and TRAcelet(TM) compression device, all of which received U.S. FDA (Food and Drug Administration) clearance and CE Mark for use in diagnostic cardiac catheterization procedures and percutaneous coronary intervention (PCI).

    The DxTerity and DxTerity TRA Diagnostic Catheters, TRAcelet compression device and the InTRAkit Access Kit are commercially available in the U.S., as well as throughout Europe. The Transradial Arc Curriculum is only available in the U.S.

    Source: Medtronic

    Share
Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.

Share